In a recent article from China, a transferable resistance mechanism has been described in Escherichia

; coli (E. coli), isolated from food-producing animals, meat and hospital patients (Liu et al., 2015).

; Recently, this resistance mechanism has also been found in Denmark, France, the United Kingdom and

; Belgium. Colistin is considered as one of the last resort treatments against multi-resistant bacteria in

; human medicine, especially for patients with cystic fibrosis. Alertness is needed and the new resistance

; mechanism has to be detected properly in animal and human related bacteria.